Qi Zhao – InmunoES

Sintilimab-induced toxic epidermal necrolysis complicated in advanced gastric cancer: a case report and literature review

2 de March de 2026 by Qi Zhao

BackgroundImmune checkpoint inhibitors (ICIs) can trigger immune-related adverse events (irAEs), among which Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is exceptionally rare but potentially fatal. Sintilimab, a PD-1 inhibitor increas…

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study

21 de August de 2025 by Qi Zhao

BackgroundWhile neoadjuvant chemoimmunotherapy shows promise for locally advanced esophageal squamous cell carcinoma (ESCC), optimal regimen selection remains challenging. This study compares perioperative outcomes between camrelizumab- and tislelizuma…